Literature DB >> 16912230

Ikaros is required for plasmacytoid dendritic cell differentiation.

David Allman1, Marc Dalod, Carine Asselin-Paturel, Thomas Delale, Scott H Robbins, Giorgio Trinchieri, Christine A Biron, Philippe Kastner, Susan Chan.   

Abstract

Plasmacytoid dendritic cells (pDCs) are specialized DCs that produce high levels of type I IFN upon viral infection. Despite their key immunoregulatory role, little is known about pDC ontogeny or how developmental events regulate their function. We show that mice expressing low levels of the transcription factor Ikaros (Ik(L/L)) lack peripheral pDCs, but not other DC subsets. Loss of pDCs is associated with an inability to produce type I IFN after challenge with Toll-like receptor-7 and -9 ligands, or murine cytomegalovirus (MCMV) infection. In contrast, conventional DCs are present in normal numbers and exhibit normal responses in vivo after challenge with MCMV or inactivated toxoplasma antigen. Interestingly, Ik(L/L) bone marrow (BM) cells contain a pDC population that appears blocked at the Ly-49Q- stage of differentiation and fails to terminally differentiate in response to Flt-3L, a cytokine required for pDC differentiation. This differentiation block is strictly dependent on a cell-intrinsic requirement for Ikaros in pDC-committed precursors. Global gene expression profiling of Ik(L/L) BM pDCs reveals an up-regulation of genes not normally expressed, or expressed at low levels, in WT pDCs. These studies suggest that Ikaros controls pDC differentiation by silencing a large array of genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912230      PMCID: PMC1895449          DOI: 10.1182/blood-2006-03-007757

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  63 in total

1.  Distinct signals control the hematopoiesis of lymphoid-related dendritic cells.

Authors:  A Galy; I Christopherson; G Ferlazzo; G Liu; H Spits; K Georgopoulos
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

2.  CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.

Authors:  O Schulz; A D Edwards; M Schito; J Aliberti; S Manickasingham; A Sher; C Reis e Sousa
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

3.  Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

Authors:  L Chaperot; N Bendriss; O Manches; R Gressin; M Maynadie; F Trimoreau; H Orfeuvre; B Corront; J Feuillard; J J Sotto; J C Bensa; F Brière; J Plumas; M C Jacob
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

4.  Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.

Authors:  P Sabbattini; M Lundgren; A Georgiou; C Chow ; G Warnes; N Dillon
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Authors:  A Le Bon; G Schiavoni; G D'Agostino; I Gresser; F Belardelli; D F Tough
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

6.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

Authors:  M Cella; F Facchetti; A Lanzavecchia; M Colonna
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

7.  Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors.

Authors:  M Kuwana; J Kaburaki; T M Wright; Y Kawakami; Y Ikeda
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

8.  Natural interferon alpha/beta-producing cells link innate and adaptive immunity.

Authors:  N Kadowaki; S Antonenko; J Y Lau; Y J Liu
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2.

Authors:  H Spits; F Couwenberg; A Q Bakker; K Weijer; C H Uittenbogaart
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

10.  CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.

Authors:  H Nakano; M Yanagita; M D Gunn
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  59 in total

Review 1.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

Review 2.  The role of type I interferon production by dendritic cells in host defense.

Authors:  P Fitzgerald-Bocarsly; D Feng
Journal:  Biochimie       Date:  2007-05-08       Impact factor: 4.079

Review 3.  Understanding the multiple functions of Gr-1(+) cell subpopulations during microbial infection.

Authors:  Charlotte E Egan; Woraporn Sukhumavasi; Allison L Bierly; Eric Y Denkers
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Authors:  Patricia Fitzgerald-Bocarsly; Jihong Dai; Sukhwinder Singh
Journal:  Cytokine Growth Factor Rev       Date:  2008-01-11       Impact factor: 7.638

Review 5.  Dendritic cell homeostasis.

Authors:  Miriam Merad; Markus G Manz
Journal:  Blood       Date:  2009-01-27       Impact factor: 22.113

6.  Ikaros represses the transcriptional response to Notch signaling in T-cell development.

Authors:  Eva Kleinmann; Anne-Solen Geimer Le Lay; MacLean Sellars; Philippe Kastner; Susan Chan
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

Review 7.  A STATus report on DC development.

Authors:  Haiyan S Li; Stephanie S Watowich
Journal:  J Leukoc Biol       Date:  2012-05-01       Impact factor: 4.962

8.  Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota.

Authors:  Daisuke Fujiwara; Bo Wei; Laura L Presley; Sarah Brewer; Michael McPherson; Michael A Lewinski; James Borneman; Jonathan Braun
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 9.  TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.

Authors:  Melissa Swiecki; Stephen A McCartney; Yaming Wang; Marco Colonna
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

Review 10.  Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance?

Authors:  N M Rogers; J S Isenberg; A W Thomson
Journal:  Am J Transplant       Date:  2013-04-25       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.